Español
PrintEmail
Decrease (-) Restore Default Increase (+)
In This Section Texas Health Dallas
Find a Physician
James Fredric Strauss, MD
2692.jpg This physician is accepting new patients. Click the button below to request an appointment, or call 1-877-THR-WELL for assistance. 

 

Clinic or Practice Name  Texas Oncology, PA
Ste 700
8220 Walnut Hill Lane
Dallas
TX, 75231

Street Map
Phone   (214) 739-4175
Fax   (214) 987-4161
Hours   Monday: 08:30 a.m. - 5:00 p.m.
Tuesday: 08:30 a.m. - 5:00 p.m.
Wednesday: 08:30 a.m. - 5:00 p.m.
Thursday: 08:30 a.m. - 5:00 p.m.
Friday: 08:30 a.m. - 5:00 p.m.
Age   66
Gender   Male
Specialties   Hematology/Oncology, Oncology, Internal Medicine
Board Certifications   Certified in Hematology/Oncology, Oncology, Internal Medicine
Insurances  
Same Day Appointment?   No
Primary Hospital   Texas Health Dallas
Practice Type   Group
Practicing Since   1980
Medical Education   New York University School of Medicine-New York, NY
Internship   Los Angeles County Health Care Facilities-Los Angeles, CA
Residency   Baylor University Medical Center-Dallas, TX
Fellowship   UT Southwestern Medical Center-Dallas, TX
Clinical Trials   Primary GI tromal Tumor (Gastrointestinal Cancer)

A PHASE II STUDY OF ADJUVANT ST1571 (GLEEVAC) (Gastrointestinal Cancer)

A PHASE III DOUBLE BLIND STUDY OF LETROZOLE VERSUS PLACEBO IN WOMEN WITH PRIMARY BREAST CANCER

A Study of Adjuvant Sunitinib vs Sorafenib vs Placebo in Patients with Resected Renal Cell Cancer

ADJUVANT CLODRONATE THERAPY VS PLACEBO IN EARLY-STAGE BREAST CANCER

ADJUVANT TREATMENT OF RESECTED PANCREATIC CANCER (Pancreatic Cancer)

P622 NSABP B-33 (Breast Cancer)

Prevention of Alzheimer's Disease With Vitamin E and Selenium in Prostate Cancer Patients

SELENIUM AND VITAMIN E CANCER PREVENTION TRIAL (SELECT) (Prostate Cancer)

STUDY OF TAMOXIFEN AND RALOXIFENE (STAR) FOR THE PREVENTION OF BREAST CANCER (Breast Cancer)

Suppression of Ovarian Function Plus Either Tamoxifen or Exemestane Compared With Tamoxifen Alone in Treating Premenopausal Women With Hormone-Responsive Breast Cancer

SWOG 9808

The Expression Project for Oncology (expO) (Cancer)

TRIAL COMPARING INFUSIONAL 5-FLUOROURACIL, LEUCOVORIN, AND OXALIPLATIN EVERY TWO WEEKS WITH BEVACIZUMAB TO THE SAME REGIMEN WITHOUT BEVACIZUMAB FOR THE TREATMENT OF PATIENTS WITH RESECTED STAGE II AND III CARCINOMA OF THE COLON (Colon Cancer)

Find a physician on the medical staff at Texas Health Presbyterian Hospital–WNJ in Sherman.

Note: This directory is sponsored by Texas Health Resources. Physicians listed herein are members of the medical staff of a Texas Health hospital or joint venture facility and are neither employees nor agents of the hospital or Texas Health Resources, except for residents in the graduate medical education program at Texas Health Presbyterian Hospital Dallas. However, some physicians are employed by Texas Health Physicians Group, an entity affiliated with Texas Health Resources. This service is free. There is no charge or fee to end-users nor to the physicians, except those who may be joint venture investors. All doctors listed herein voluntarily agree to the display of information about their respective practices. The physician information is for reference only. Please check with the physician(s) directly to verify accuracy of the information provided. Providers with a primary specialty of radiology, anesthesiology, pathology, emergency medicine, or neonatology are facility-based physicians as defined by state law.

Physicians: Follow this link to update the content of your online profile using the CareGate Physician Portal.

After logging in, select:   My Account > My Profile > Physician Referral Service